Ascom (OTCMKTS:ACMLF) & DarioHealth (NASDAQ:DRIO) Financial Review

DarioHealth (NASDAQ:DRIO) and Ascom (OTCMKTS:ACMLF) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk.

Profitability

This table compares DarioHealth and Ascom’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DarioHealth	-192.23%	-60.52%	-37.08%
Ascom	N/A	N/A	N/A

Valuation and Earnings

This table compares DarioHealth and Ascom”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36 million	2.40	-$41.71 million	($8.88)	-0.82
Ascom	N/A	N/A	N/A	N/A	N/A

Ascom has lower revenue, but higher earnings than DarioHealth.

Institutional & Insider Ownership

33.4% of DarioHealth shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and price targets for DarioHealth and Ascom, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1	1	1	0	2.00
Ascom	0	0	0	0	0.00

DarioHealth currently has a consensus price target of $10.50, indicating a potential upside of 43.84%. Given DarioHealth’s stronger consensus rating and higher probable upside, research analysts plainly believe DarioHealth is more favorable than Ascom.

Summary

DarioHealth beats Ascom on 6 of the 9 factors compared between the two stocks.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

About Ascom

Ascom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. The company offers nurse call and monitoring systems, including teleCARE IP that provides wireless nurse call, alerts, messaging, monitoring, and wander management solution; and Telligence, a patient response system. It also provides Digistat, a suite of clinical workflow software; Unite software, a workflow orchestration platform that integrates data and events from source systems, as well as offers alerts, chats, and tasks to enable users on various endpoint platforms; and Ofelia for managing tasks and workflows. In addition, the company offers mobile devices, such as smartphones, DECT and VoWiFi phones, and pagers solutions. Further, it offers consulting, implementation, training, support, and maintenance services. The company is headquartered in Baar, Switzerland.